Ruizan Shi

485 total citations
21 papers, 408 citations indexed

About

Ruizan Shi is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Ruizan Shi has authored 21 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Ruizan Shi's work include Air Quality and Health Impacts (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Cancer Cells and Metastasis (3 papers). Ruizan Shi is often cited by papers focused on Air Quality and Health Impacts (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Cancer Cells and Metastasis (3 papers). Ruizan Shi collaborates with scholars based in China, Hong Kong and United States. Ruizan Shi's co-authors include Mingsheng Zhang, Chang Wang, Gang Qin, Min Chen, Xuanping Zhang, Dongsheng Xiong, Dongmei Fan, Jianfeng Xing, Zehui Wei and Feng Bai and has published in prestigious journals such as PLoS ONE, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Ruizan Shi

20 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruizan Shi China 14 193 95 59 53 48 21 408
Zhaohui Cao China 11 163 0.8× 48 0.5× 23 0.4× 45 0.8× 71 1.5× 17 374
Moran Wang China 10 177 0.9× 52 0.5× 49 0.8× 25 0.5× 50 1.0× 25 508
Nadica Matevska-Geshkovska North Macedonia 13 247 1.3× 64 0.7× 48 0.8× 31 0.6× 38 0.8× 33 531
M. Suzanne Stratton United States 14 127 0.7× 82 0.9× 101 1.7× 128 2.4× 71 1.5× 23 628
Venkatesh Kolluru United States 14 265 1.4× 78 0.8× 63 1.1× 79 1.5× 118 2.5× 20 516
Bradley Miller United States 13 324 1.7× 89 0.9× 45 0.8× 51 1.0× 158 3.3× 27 683
Peter Grešner Poland 15 222 1.2× 66 0.7× 49 0.8× 65 1.2× 89 1.9× 25 558
Yanying Zhou China 12 176 0.9× 60 0.6× 28 0.5× 89 1.7× 72 1.5× 35 479
Yizhen Li China 13 174 0.9× 58 0.6× 37 0.6× 27 0.5× 72 1.5× 39 419
Hironori Kanda Japan 13 225 1.2× 60 0.6× 70 1.2× 90 1.7× 13 0.3× 19 522

Countries citing papers authored by Ruizan Shi

Since Specialization
Citations

This map shows the geographic impact of Ruizan Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruizan Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruizan Shi more than expected).

Fields of papers citing papers by Ruizan Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruizan Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruizan Shi. The network helps show where Ruizan Shi may publish in the future.

Co-authorship network of co-authors of Ruizan Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Ruizan Shi. A scholar is included among the top collaborators of Ruizan Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruizan Shi. Ruizan Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Yu, Ruihan Li, Wenlong Zhang, et al.. (2023). Metformin Alleviates Sepsis-Associated Myocardial Injury by Enhancing AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Signaling Pathway–Mediated Autophagy. Journal of Cardiovascular Pharmacology. 82(4). 308–317. 8 indexed citations
2.
Chen, Min, et al.. (2021). Chrysin prevents lipopolysaccharide-induced acute lung injury in mice by suppressing the IRE1α/TXNIP/NLRP3 pathway. Pulmonary Pharmacology & Therapeutics. 68. 102018–102018. 22 indexed citations
3.
4.
Shi, Ruizan, Linhong Liu, Yifan He, et al.. (2020). Downregulation of cytokeratin 18 induces cellular partial EMT and stemness through increasing EpCAM expression in breast cancer. Cellular Signalling. 76. 109810–109810. 32 indexed citations
5.
6.
Shi, Ruizan, Zehui Wei, Chang Wang, et al.. (2018). Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition. Life Sciences. 207. 442–450. 33 indexed citations
7.
Zhang, Fei, et al.. (2018). Nephroprotective effects of nebivolol in 2K1C rats through regulation of the kidney ROS-ADMA-NO pathway. Pharmacological Reports. 70(5). 917–929. 12 indexed citations
8.
Zhang, Fei, et al.. (2018). Nebivolol ameliorated kidney damage in Zucker diabetic fatty rats by regulation of oxidative stress/NO pathway: Comparison with captopril. Clinical and Experimental Pharmacology and Physiology. 45(11). 1135–1148. 16 indexed citations
9.
Shi, Ruizan, Zehui Wei, Chang Wang, et al.. (2017). Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats. Pulmonary Pharmacology & Therapeutics. 48. 124–135. 48 indexed citations
10.
11.
Chen, Min, Mingsheng Zhang, Xuanping Zhang, et al.. (2015). Limb Ischemic Preconditioning Protects Endothelium from Oxidative Stress by Enhancing Nrf2 Translocation and Upregulating Expression of Antioxidases. PLoS ONE. 10(6). e0128455–e0128455. 20 indexed citations
12.
Fan, Dongmei, Ming Yang, Yan Yan, et al.. (2013). Cytosine Arabinoside Promotes Cytotoxic Effect of T Cells on Leukemia Cells Mediated by Bispecific Antibody. Human Gene Therapy. 24(8). 751–760. 7 indexed citations
13.
Shi, Ruizan, Hongwei Peng, Xiangfei Yuan, et al.. (2013). Down‐regulation of c‐fos by shRNA sensitizes adriamycin‐resistant MCF‐7/ADR cells to chemotherapeutic agents via P‐glycoprotein inhibition and apoptosis augmentation. Journal of Cellular Biochemistry. 114(8). 1890–1900. 33 indexed citations
14.
Peng, Hongwei, Xiangfei Yuan, Ruizan Shi, et al.. (2013). PHII-7 inhibits cell growth and induces apoptosis in leukemia cell line K562 as well as its MDR- counterpart K562/A02 through producing reactive oxygen species. European Journal of Pharmacology. 718(1-3). 459–468. 13 indexed citations
15.
Li, Caiping, et al.. (2012). Ginsenoside Rg1 reduces toxicity of PM2.5 on human umbilical vein endothelial cells by upregulating intracellular antioxidative state. Environmental Toxicology and Pharmacology. 35(1). 21–29. 22 indexed citations
16.
Li, Wei, Dongmei Fan, Ming Yang, et al.. (2012). Disulfide-stabilized diabody antiCD19/antiCD3 exceeds its parental antibody in tumor-targeting activity. Cellular Oncology. 35(6). 423–434. 9 indexed citations
17.
18.
Shi, Ruizan, Xiao Hu, & Hongwei Peng. (2012). [The cytotoxicity of indirubin derivative PHII-7 against human breast cancer MCF-7 cells and its mechanisms].. PubMed. 32(11). 1521–5. 1 indexed citations
19.
Shi, Ruizan, Wěi Li, Xiuli Zhang, et al.. (2011). A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells. European Journal of Pharmacology. 669(1-3). 38–44. 21 indexed citations
20.
Liu, Rong, Wen G. Jiang, Ming Yang, et al.. (2010). Efficient Inhibition of Human B-cell Lymphoma in SCID Mice by Synergistic Antitumor Effect of Human 4-1BB Ligand/Anti-CD20 Fusion Proteins and Anti-CD3/Anti-CD20 Diabodies. Journal of Immunotherapy. 33(5). 500–509. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhaohui Cao Breakdown of academic impact, for papers by Moran Wang Breakdown of academic impact, for papers by Nadica Matevska-Geshkovska Breakdown of academic impact, for papers by M. Suzanne Stratton Breakdown of academic impact, for papers by Venkatesh Kolluru Breakdown of academic impact, for papers by Bradley Miller Breakdown of academic impact, for papers by Peter Grešner Breakdown of academic impact, for papers by Yanying Zhou Breakdown of academic impact, for papers by Yizhen Li Breakdown of academic impact, for papers by Hironori Kanda
Rankless by CCL
2026